These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32366575)

  • 1. Achromobacter xylosoxidans Cellular Pathology Is Correlated with Activation of a Type III Secretion System.
    Pickrum AM; DeLeon O; Dirck A; Tessmer MH; Riegert MO; Biller JA; Ledeboer NA; Kirby JR; Frank DW
    Infect Immun; 2020 Jun; 88(7):. PubMed ID: 32366575
    [No Abstract]   [Full Text] [Related]  

  • 2. The
    Pickrum AM; Riegert MO; Wells C; Brockman K; Frank DW
    Microbiol Spectr; 2022 Aug; 10(4):e0208322. PubMed ID: 35856670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the
    Le Goff M; Vastel M; Lebrun R; Mansuelle P; Diarra A; Grandjean T; Triponney P; Imbert G; Gosset P; Dessein R; Garnier F; Durand E
    Front Cell Infect Microbiol; 2022; 12():859181. PubMed ID: 35782124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A heat-stable cytotoxic factor produced by Achromobacter xylosoxidans isolated from Brazilian patients with CF is associated with in vitro increased proinflammatory cytokines.
    Mantovani RP; Levy CE; Yano T
    J Cyst Fibros; 2012 Jul; 11(4):305-11. PubMed ID: 22440828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemic Achromobacter xylosoxidans strain among Belgian cystic fibrosis patients and review of literature.
    Cools P; Ho E; Vranckx K; Schelstraete P; Wurth B; Franckx H; Ieven G; Van Simaey L; Van Daele S; Verhulst S; De Baets F; Vaneechoutte M
    BMC Microbiol; 2016 Jun; 16(1):122. PubMed ID: 27342812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic Airway Colonization by Achromobacter xylosoxidans in Cystic Fibrosis Patients Is Not Sustained by Their Domestic Environment.
    Dupont C; Jumas-Bilak E; Doisy C; Aujoulat F; Chiron R; Marchandin H
    Appl Environ Microbiol; 2018 Dec; 84(23):. PubMed ID: 30217850
    [No Abstract]   [Full Text] [Related]  

  • 7. Patterns of virulence factor expression and antimicrobial resistance in Achromobacter xylosoxidans and Achromobacter ruhlandii isolates from patients with cystic fibrosis.
    Pereira RH; Leão RS; Carvalho-Assef AP; Albano RM; Rodrigues ER; Firmida MC; Folescu TW; Plotkowski MC; Bernardo VG; Marques EA
    Epidemiol Infect; 2017 Feb; 145(3):600-606. PubMed ID: 27873565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukotriene B
    Prado MKB; Locachevic GA; Zoccal KF; Paula-Silva FWG; Fontanari C; Ferreira JC; Pereira PAT; Gardinassi LG; Ramos SG; Sorgi CA; Darini ALC; Faccioli LH
    Sci Rep; 2017 Dec; 7(1):17658. PubMed ID: 29247243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pan-Resistant Achromobacter xylosoxidans and Stenotrophomonas maltophilia Infection in Cystic Fibrosis Does Not Reduce Survival After Lung Transplantation.
    Lobo LJ; Tulu Z; Aris RM; Noone PG
    Transplantation; 2015 Oct; 99(10):2196-202. PubMed ID: 25856407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of the species of Achromobacter in a French Cystic Fibrosis Centre and multilocus sequence typing analysis reveal the predominance of A. xylosoxidans and clonal relationships between some clinical and environmental isolates.
    Amoureux L; Bador J; Bounoua Zouak F; Chapuis A; de Curraize C; Neuwirth C
    J Cyst Fibros; 2016 Jul; 15(4):486-94. PubMed ID: 26778615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Achromobacter xylosoxidans genomic characterization and correlation of randomly amplified polymorphic DNA profiles with relevant clinical features [corrected] of cystic fibrosis patients.
    Magni A; Trancassini M; Varesi P; Iebba V; Curci A; Pecoraro C; Cimino G; Schippa S; Quattrucci S
    J Clin Microbiol; 2010 Apr; 48(4):1035-9. PubMed ID: 20107101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients.
    Hansen CR; Pressler T; Nielsen KG; Jensen PØ; Bjarnsholt T; Høiby N
    J Cyst Fibros; 2010 Jan; 9(1):51-8. PubMed ID: 19939747
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Menetrey Q; Sorlin P; Jumas-Bilak E; Chiron R; Dupont C; Marchandin H
    Genes (Basel); 2021 Apr; 12(5):. PubMed ID: 33919046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duplex real-time PCR assay for the simultaneous detection of
    Price EP; Soler Arango V; Kidd TJ; Fraser TA; Nguyen TK; Bell SC; Sarovich DS
    Microb Genom; 2020 Jul; 6(7):. PubMed ID: 32667877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe Achromobacter xylosoxidans infection and loss of sputum bacterial diversity in an adult patient with cystic fibrosis.
    Talbot NP; Flight WG
    Paediatr Respir Rev; 2016 Aug; 20 Suppl():27-9. PubMed ID: 27374622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Achromobacter xylosoxidans infection in an adult cystic fibrosis unit in Madrid.
    Llorca Otero L; Girón Moreno R; Buendía Moreno B; Valenzuela C; Guiu Martínez A; Alarcón Cavero T
    Enferm Infecc Microbiol Clin; 2016 Mar; 34(3):184-7. PubMed ID: 26139304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phage therapy against Achromobacter xylosoxidans lung infection in a patient with cystic fibrosis: a case report.
    Hoyle N; Zhvaniya P; Balarjishvili N; Bolkvadze D; Nadareishvili L; Nizharadze D; Wittmann J; Rohde C; Kutateladze M
    Res Microbiol; 2018 Nov; 169(9):540-542. PubMed ID: 29777836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Achromobacter xylosoxidans induced bronchiolitis obliterans in cystic fibrosis.
    De Baets F; Schelstraete P; Haerynck F; Van Biervliet S; De Bruyne R; Franckx H; Van Daele S
    Pediatr Pulmonol; 2014 Apr; 49(4):414-6. PubMed ID: 24039244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance.
    De Baets F; Schelstraete P; Van Daele S; Haerynck F; Vaneechoutte M
    J Cyst Fibros; 2007 Jan; 6(1):75-8. PubMed ID: 16793350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescence in situ hybridization for rapid identification of Achromobacter xylosoxidans and Alcaligenes faecalis recovered from cystic fibrosis patients.
    Wellinghausen N; Wirths B; Poppert S
    J Clin Microbiol; 2006 Sep; 44(9):3415-7. PubMed ID: 16954289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.